This inventor holds 33 USPTO granted patents and 1 published patent application and 6 EPO patents, primarily in Biotechnology Enzymes. Top assignees: Novozymes A/s, Novo Nordisk A/s, Novozymes, Inc.. Active years: 1993-2016.
Location History:
- Charlottenlund, DK (1993 - 1999)
- Hiller.o slashed.d, DK (1998 - 2000)
- Hilerød, DK (2001)
- Hillerød, DK (2001 - 2013)
- Birkerod, DK (2010 - 2013)
- Hillerod, DK (2005 - 2014)
- Birkeroed, DK (2013 - 2016)
Company Filing History:
18 out of 1,422 
12 out of 1,801 
5 out of 384 
Years Active: 1993-2016
Areas of Expertise:
Title: Discovering the Innovations of Ib Groth Clausen
Introduction
Ib Groth Clausen, located in Birkeroed, Denmark, is a notable inventor recognized for his significant contributions to biotechnology. With an impressive portfolio of 33 patents, Clausen has made remarkable advancements centering around polypeptides that exhibit cellobiohydrolase I activity.
Latest Patents
Clausen's latest innovations include patents focused on polypeptides having cellobiohydrolase I activity and corresponding polynucleotides encoding the same. The inventions include not only the polypeptides but also nucleic acid constructs, vectors, and host cells that incorporate these nucleic acid constructs. Additionally, Clausen has developed methods for producing and utilizing these polypeptides, further demonstrating his commitment to enhancing biotechnological applications.
Career Highlights
Throughout his career, Ib Groth Clausen has worked with prominent companies such as Novozymes A/S and Novo Nordisk A/S. His experience in these leading biotechnology firms has undoubtedly played a pivotal role in shaping his expertise and innovative capabilities in the field.
Collaborations
Clausen has had the opportunity to collaborate with esteemed colleagues, including Lene Lange and Wenping Wu. These professional relationships have fostered a dynamic exchange of ideas and advancements in biotechnology, contributing to Clausen’s substantial patent portfolio.
Conclusion
Ib Groth Clausen is a pioneering inventor in the biotech sector, with a solid record of 33 patents to his name. His latest innovations emphasize the potential of polypeptides and polynucleotides, which could lead to groundbreaking applications in various industries. Clausen’s collaboration with other respected professionals further enhances the impact of his work, solidifying his reputation as a significant contributor to the field of innovation.